| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |